Cancer is deemed as one of the most glaring causes of mortality and morbidity across the world. Due to advancements in technology and a significant amount of research, the oncology nutrition market is expected to witness considerable growth in the coming years. Oncology nutrition continues to remain an imperative area of focus for healthcare providers due to a consistent rise in the number of cases of malnutrition induced by tumors worldwide. Oncology nutrition plays an important role in improving bodily resources, tolerance of cancer treatments, and the overall quality of life. The decline in tolerance to cancer therapy is expected to provide fertile grounds of growth for companies operating in the current oncology nutrition market.
The significant rise in nutritional wasting and nutritional risk among cancer patients is a major factor that is anticipated to boost the growth of the oncology nutrition market during the forecast period. Participants in the current market landscape are currently investigating the potential benefits of adopting a multidisciplinary approach wherein targeted nutrition is likely to be imperative to enhance the quality of oncology care. Evolving guidelines, surge in observational studies, and growth in the number of clinical trials worldwide are some of the leading factors that are expected to propel the growth of the market for oncology nutrition in the coming years. At the back of these factors, the global oncology nutrition market is expected to reach ~US$ 1.4 Bn by the end of 2027.
To know the scope of our report Get a Sample on Oncology Nutrition Market
Nutritional screening and assessment techniques are integral to detect the identification of patients that are at a greater risk of malnourishment. Several studies have revealed that the incorporation of malnutrition screening in oncology care is expected to improve nutritional assessment and prevent malnutrition among patients. While nutritional risk continues to come under the radar, oncology nutrition is projected to gain a fair amount of momentum over the course of the assessment period. The demand for oncology nutrition is expected to further grow due to the notable surge in the adoption of nutritional assessment programs particularly during cancer cachexia and precachexia. Data collection techniques pertaining to the nutritional status of various patients have progressed at a rapid pace over the past decade. Due to these advancements, tailored oncology nutrition therapies have emerged as an ideal solution for cancer patients who are susceptible to malnutrition.
Get a glimpse of the in-depth analysis through our Report Brochure
Oncology nutrition therapies vary from patients to patients and at present, individualized oncology nutritional counseling has gained considerable pace. Oncology nutrition is increasingly being used to prevent nutritional deterioration among patients who are undergoing cancer care. Oral oncology nutrition is likely to gain considerable popularity as it has emerged as the preferred route of feeding. The demand for oncology nutrition to enhance the quality of life in cancer patients is on the rise– a major factor that is expected to provide a significant boost to the growth of the oncology nutrition market during the assessment period.
One of the most glaring challenges that participants in the oncology nutrition market have had to deal with over several decades is the inadequate and unclear guidelines laid down by authoritative bodies due to which, oncology nutrition remained at the backseat. However, with additional research and growing awareness regarding the benefits of oncology nutrition, the structure within the healthcare systems is evolving. At present, within the oncology nutrition market, clinical nutrition specialists and oncologists are increasingly collaborating with each other in their efforts to improve oncology nutrition and oncology care. At present, recently laid down guidelines from different scientific bodies have focused on some key areas that are expected to improve the adoption of oncology nutrition in the coming years, including regular oncology nutritional therapy particularly for malnourished cancer patients, home artificial nutrition prescription, nutritional management, etc. The new guidelines would offer a boost to the adoption of oncology nutrition in the coming years, as the uptake of improved oncology nutrition therapies for cancer patients undergoing chemoradiotherapy is on the rise.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The global oncology nutrition market is expected to grow at a healthy CAGR of ~6% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising in the prevalence of cancer patients, technological advancements, research & development activities, and growing awareness regarding oncology nutrition are some of the leading factors that will provide an impetus to the growth of the market for oncology nutrition during the forecast period. Focus on improving nutritional assessment among cancer patients due to the rise in the number of malnutrition cases will also play an important role in boosting the growth of the oncology nutrition market.
Oncology Nutrition Market - Segmentation
Distribution Channel |
Inpatient Nutrition Outpatient Nutrition |
Nutrition |
Enteral Nutrition Parenteral Nutrition |
Formula |
Standard Formula Elemental Formula Specialized Formula |
Cancer |
Head and Neck Cancers Colorectal Cancer Hematology Cancer Prostate Cancer Breast Cancer Gastrointestinal Cancer Lung Cancer Pancreatic Cancer Others |
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
The global oncology nutrition market was worth US$ 836 Mn and is projected to reach a value of US$ 1.4 Bn by the end of 2027
Oncology nutrition market is anticipated to grow at a CAGR of 6% during the forecast period
North America accounted for a major share of the global oncology nutrition market
Oncology nutrition market is driven by growing incidence of cancer, cancer supportive care products to meet the growing demand to treat cancer, entry of new players, and increase in access to health care are anticipated to drive the global market
Key players in the global oncology nutrition market include Danone S.A., Pfizer Inc., B.Braun Melsungen AG, Fresenius Kabi AG, Grifols, S.A., Baxter International, Inc., Nestlé S.A., Abbott Laboratories, Sichuan Kelun Pharmaceutical Co., Ltd
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oncology Nutrition Market
4. Market Overview
4.1. Introduction
4.1.1. Formula Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oncology Nutrition Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Health Care Industry Overview
5.2. Cancer Incidence, by Key Country, in 2017
6. Global Oncology Nutrition Market Analysis and Forecast, by Nutrition
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Oncology Nutrition Market Value Forecast, by Nutrition, 2017–2027
6.2.1. Enteral Nutrition
6.2.2. Parenteral Nutrition
6.3. Global Oncology Nutrition Market Attractiveness, by Nutrition
7. Global Oncology Nutrition Market Analysis and Forecast, by Formula
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Oncology Nutrition Market Value Forecast, by Formula, 2017–2027
7.2.1. Standard Formula
7.2.2. Elemental Formula
7.2.3. Specialized Formula
7.3. Global Oncology Nutrition Market Attractiveness, by Formula
8. Global Oncology Nutrition Market Analysis and Forecast, by Cancer
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Oncology Nutrition Market Value Forecast, by Cancer, 2017–2027
8.2.1. Head and Neck Cancers
8.2.2. Colorectal Cancer
8.2.3. Hematology Cancer
8.2.4. Prostate Cancer
8.2.5. Breast Cancer
8.2.6. Gastrointestinal Cancer
8.2.7. Lung Cancer
8.2.8. Pancreatic Cancer
8.2.9. Other Cancers
8.3. Global Oncology Nutrition Market Attractiveness, by Cancer
9. Global Oncology Nutrition Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.1.1. Key Findings / Developments
9.2. Global Oncology Nutrition Market Value Forecast, by Distribution Channel, 2017–2027
9.2.1. Inpatient Nutrition
9.2.2. Outpatient Nutrition
9.3. Global Oncology Nutrition Market Attractiveness, by Distribution Channel
10. Global Oncology Nutrition Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Oncology Nutrition Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. North America Oncology Nutrition Market Attractiveness, by Region
11. North America Oncology Nutrition Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
11.2.1. Enteral Nutrition
11.2.2. Parenteral Nutrition
11.3. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
11.3.1. Standard Formula
11.3.2. Elemental Formula
11.3.3. Specialized Formula
11.4. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
11.4.1. Head and Neck Cancers
11.4.2. Colorectal Cancer
11.4.3. Hematology Cancer
11.4.4. Prostate Cancer
11.4.5. Breast Cancer
11.4.6. Gastrointestinal Cancer
11.4.7. Lung Cancer
11.4.8. Pancreatic Cancer
11.4.9. Other Cancers
11.5. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
11.5.1. Inpatient Nutrition
11.5.2. Outpatient Nutrition
11.6. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Oncology Nutrition Market Attractiveness Analysis
11.7.1. By Nutrition
11.7.2. By Formula
11.7.3. By Cancer
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Oncology Nutrition Market Analysis and Forecast
12.1. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
12.1.1. Enteral Nutrition
12.1.2. Parenteral Nutrition
12.2. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
12.2.1. Standard Formula
12.2.2. Elemental Formula
12.2.3. Specialized Formula
12.3. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
12.3.1. Head and Neck Cancers
12.3.2. Colorectal Cancer
12.3.3. Hematology Cancer
12.3.4. Prostate Cancer
12.3.5. Breast Cancer
12.3.6. Gastrointestinal Cancer
12.3.7. Lung Cancer
12.3.8. Pancreatic Cancer
12.3.9. Other Cancers
12.4. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
12.4.1. Inpatient Nutrition
12.4.2. Outpatient Nutrition
12.5. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. Germany
12.5.2. U.K.
12.5.3. France
12.5.4. Spain
12.5.5. Italy
12.5.6. Rest of Europe
12.6. Europe Oncology Nutrition Market Attractiveness Analysis
12.6.1. By Nutrition
12.6.2. By Formula
12.6.3. By Cancer
12.6.4. By Distribution Channel
12.6.5. By Country/Sub-region
13. Asia Pacific Oncology Nutrition Market Analysis and Forecast
13.1. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
13.1.1. Enteral Nutrition
13.1.2. Parenteral Nutrition
13.2. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
13.2.1. Standard Formula
13.2.2. Elemental Formula
13.2.3. Specialized Formula
13.3. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
13.3.1. Head and Neck Cancers
13.3.2. Colorectal Cancer
13.3.3. Hematology Cancer
13.3.4. Prostate Cancer
13.3.5. Breast Cancer
13.3.6. Gastrointestinal Cancer
13.3.7. Lung Cancer
13.3.8. Pancreatic Cancer
13.3.9. Other Cancers
13.4. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
13.4.1. Inpatient Nutrition
13.4.2. Outpatient Nutrition
13.5. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. Japan
13.5.3. India
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Oncology Nutrition Market Attractiveness Analysis
13.6.1. By Nutrition
13.6.2. By Formula
13.6.3. By Cancer
13.6.4. By Distribution Channel
13.6.5. By Country/Sub-region
14. Latin America Oncology Nutrition Market Analysis and Forecast
14.1. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
14.1.1. Enteral Nutrition
14.1.2. Parenteral Nutrition
14.2. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
14.2.1. Standard Formula
14.2.2. Elemental Formula
14.2.3. Specialized Formula
14.3. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
14.3.1. Head and Neck Cancers
14.3.2. Colorectal Cancer
14.3.3. Hematology Cancer
14.3.4. Prostate Cancer
14.3.5. Breast Cancer
14.3.6. Gastrointestinal Cancer
14.3.7. Lung Cancer
14.3.8. Pancreatic Cancer
14.3.9. Other Cancers
14.4. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
14.4.1. Inpatient Nutrition
14.4.2. Outpatient Nutrition
14.5. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America Latin America
14.6. Latin America Oncology Nutrition Market Attractiveness Analysis
14.6.1. By Nutrition
14.6.2. By Formula
14.6.3. By Cancer
14.6.4. By Distribution Channel
14.6.5. By Country/Sub-region
15. Middle East & Africa Oncology Nutrition Market Analysis and Forecast
15.1. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
15.1.1. Enteral Nutrition
15.1.2. Parenteral Nutrition
15.2. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
15.2.1. Standard Formula
15.2.2. Elemental Formula
15.2.3. Specialized Formula
15.3. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
15.3.1. Head and Neck Cancers
15.3.2. Colorectal Cancer
15.3.3. Hematology Cancer
15.3.4. Prostate Cancer
15.3.5. Breast Cancer
15.3.6. Gastrointestinal Cancer
15.3.7. Lung Cancer
15.3.8. Pancreatic Cancer
15.3.9. Other Cancers
15.4. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
15.4.1. Inpatient Nutrition
15.4.2. Outpatient Nutrition
15.5. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Oncology Nutrition Market Attractiveness Analysis
15.6.1. By Nutrition
15.6.2. By Formula
15.6.3. By Cancer
15.6.4. By Distribution Channel
15.6.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by Tier and Size of companies)
16.2. Market Share / Position Analysis, by Company (2018)
16.3. Company Profiles
16.3.1. Fresenius SE & Co. KGaA
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Growth Strategies
16.3.1.3. SWOT Analysis
16.3.2. Pfizer, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Growth Strategies
16.3.2.3. SWOT Analysis
16.3.3. Baxter International, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Growth Strategies
16.3.3.3. SWOT Analysis
16.3.4. B. Braun Melsungen AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Growth Strategies
16.3.4.3. SWOT Analysis
16.3.5. Abbott Laboratories
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Growth Strategies
16.3.5.3. SWOT Analysis
16.3.6. Grifols, S.A.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Growth Strategies
16.3.6.3. SWOT Analysis
16.3.7. Allergan
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Growth Strategies
16.3.7.3. SWOT Analysis
16.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Growth Strategies
16.3.8.3. SWOT Analysis
16.3.9. Nestlé S.A.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Growth Strategies
16.3.9.3. SWOT Analysis
16.3.10. Danone S.A.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Growth Strategies
16.3.10.3. SWOT Analysis
List of Tables
Table 01: Breast Cancer and Lung Cancer Incidence
Table 02: Pancreatic Cancer and Stomach Cancer Incidence
Table 03: Oral Cancer Incidence
Table 04: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 05: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 06: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 07: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 08: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 10: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 11: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 12: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 13: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 14: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 16: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 18: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 19: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 21: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 22: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 23: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 24: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 26: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 27: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 28: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
Table 29: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027
Table 31: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 32: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027
Table 33: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027
List of Figures
Figure 01: Global Oncology Nutrition Market Value (US$ Mn) Forecast, 2017–2027
Figure 02: Global Oncology Nutrition Market Value Share (%), by Cancer, 2018
Figure 03: Global Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018
Figure 04: Global Oncology Nutrition Market Value Share (%), by Formula, 2018
Figure 05: Global Oncology Nutrition Market Value Share (%), by Nutrition, 2018
Figure 06: Global Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 07: Global Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 08: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enteral nutrition,
Figure 09: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral nutrition, 2017–2027
Figure 10: Global Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 11: Global Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 12: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Inpatient Nutrition, 2017–2027
Figure 13: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Outpatient Nutrition, 2017–2027
Figure 14: Global Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 15: Global Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 16: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Standard Formula, 2017–2027
Figure 17: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Elemental Formula, 2017–2027
Figure 18: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialized Formula, 2017–2027
Figure 19: Global Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 20: Global Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027
Figure 21: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Head and Neck Cancer, 2017–2027
Figure 22: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2017–2027
Figure 23: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Cancer, 2017–2027
Figure 24: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2017–2027
Figure 25: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2017–2027
Figure 26: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Cancer, 2017–2027
Figure 27: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2017–2027
Figure 28: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pancreatic Cancer, 2017–2027
Figure 29: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Cancers, 2017–2027
Figure 30: Global Oncology Nutrition Market Value Share Analysis, by Region, 2018 and 2027
Figure 31: Global Oncology Nutrition Market Attractiveness Analysis, by Region, 2019–2027
Figure 32: North America Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 33: North America Oncology Nutrition Market Value Share Analysis, by Country, 2018 and 2027
Figure 34: North America Oncology Nutrition Market Attractiveness Analysis, by Country, 2019–2027
Figure 35: North America Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 36: North America Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 37: North America Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 38: North America Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 39: North America Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 40: North America Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 41: North America Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 42: North America Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027
Figure 43: Europe Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 44: Europe Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 45: Europe Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 46: Europe Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 47: Europe Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 48: Europe Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 49: Europe Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 50: Europe Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 51: Europe Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 52: Europe Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 53: Europe Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027
Figure 54: Asia Pacific Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 55: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 56: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 57: Asia Pacific Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 58: Asia Pacific Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 59: Asia Pacific Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 60: Asia Pacific Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 61: Asia Pacific Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 62: Asia Pacific Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 63: Asia Pacific Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 64: Asia Pacific Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027
Figure 65: Latin America Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 66: Latin America Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 67: Latin America Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 68: Latin America Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 69: Latin America Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 70: Latin America Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 71: Latin America Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 72: Latin America Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 73: Latin America Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 74: Latin America Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 75: Latin America Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027
Figure 76: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 77: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2019–2027
Figure 78: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 79: Middle East & Africa Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027
Figure 80: Middle East & Africa Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027
Figure 81: Middle East & Africa Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027
Figure 82: Middle East & Africa Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027
Figure 83: Middle East & Africa Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027
Figure 84: Middle East & Africa Oncology Nutrition Market Attractiveness, by Formula, 2019–2027
Figure 85: Middle East & Africa Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027
Figure 86: Middle East & Africa Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027